EcoDrugPlus

Si:dkey-211g8.6

Ensembl ID : ENSLOCG00000005278
Gene Symbol: SI:DKEY-211G8.6
1 Cross references
451 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSLOCG00000011271
Gene Symbol: SIRT1
3 Cross references
157 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSLOCG00000015973
Gene Symbol: SMO
3 Cross references
204 Possible Orthologues:

Sodium Channel Protein Type 4 Subunit Alpha-Like

Ensembl ID : ENSLOCG00000009914
Gene Symbol: LOC102683457
3 Cross references
332 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 4

Ensembl ID : ENSLOCG00000013195
Gene Symbol: SCN4A
2 Cross references
197 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 8

Ensembl ID : ENSLOCG00000006769
Gene Symbol: SCN8A
3 Cross references
274 Possible Orthologues:

Sodium/hydrogen Exchanger 3

Ensembl ID : ENSLOCG00000007995
Gene Symbol: LOC102687033
2 Cross references
233 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-1

Ensembl ID : ENSLOCG00000011221
Gene Symbol: LOC102689287
3 Cross references
322 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-3

Ensembl ID : ENSLOCG00000004571
Gene Symbol: LOC102682810
3 Cross references
135 Possible Orthologues:

Solute Carrier Family 10 Member 2

Ensembl ID : ENSLOCG00000008651
Gene Symbol: SLC10A2
1 Cross references
214 Possible Orthologues:

Solute Carrier Family 18 Member A2

Ensembl ID : ENSLOCG00000009666
Gene Symbol: SLC18A2
3 Cross references
224 Possible Orthologues:

Solute Carrier Family 29 Member 1a

Ensembl ID : ENSLOCG00000015621
Gene Symbol: SLC29A1A
1 Cross references
284 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).